Report in 24 hours
Booked 8 times
TPHA
Swift Insights with Immunochromatographic Testing for TPHA
৳800
৳1000
20% OFF
Sample Type
blood
Fasting Required
No
Description
TPHA test is a passive hemagglutination assay based on hemagglutination of erythrocytes sensitized with T. pallidum antigen by antibodies found in the patient’s serum or plasma. It is used for both qualitative and semi-quantitative detection of anti-treponemal antibodies.
Covid Safety
Assured
Free Report
Counselling
Recommended for You
How our test process works!
TPHA test is a passive hemagglutination assay based on hemagglutination of erythrocytes sensitized with T. pallidum antigen by antibodies found in the patient’s serum or plasma. It is used for both qualitative and semi-quantitative detection of anti-treponemal antibodies.
The purpose of the TPHA test is to detect the presence of anti-syphilis spirochetes in the plasma of a patient with syphilis.
Normal Range
- A negative result indicates no detectable antibodies to Treponema pallidum and suggests that the individual is not currently infected with syphilis.
- A positive result indicates the presence of antibodies and suggests a past or current infection with syphilis. However, a positive TPHA test alone cannot distinguish between active and past infection.
Interpretation
- Negative: No antibodies detected, which likely means the person is not infected with syphilis.
- Positive: Indicates that antibodies against Treponema pallidum are present, confirming past or present syphilis infection.
- Titers may be measured for further assessment: higher titers can suggest active syphilis.
- A positive TPHA test should be confirmed with clinical symptoms and history and may require additional tests like PCR (Polymerase Chain Reaction) or fluorescent treponemal antibody absorption (FTA-ABS) to rule out false positives.
Sample Type
- Blood Sample: The test requires a blood sample, typically drawn from a vein in the arm. The serum from the blood is then tested for the presence of Treponema pallidum antibodies.
Limitations
- False Positives: TPHA can produce false-positive results due to other conditions (e.g., other infections, autoimmune diseases, or pregnancy).
- False Negatives: In the early stages of syphilis or in individuals with a weak immune response, the test may not detect antibodies.
Frequently Asked Question
TPHA (Treponema Pallidum Hemagglutination Assay) is a serological test used to detect antibodies against Treponema pallidum, the bacterium that causes syphilis. It is used to confirm the presence of syphilis after an initial screening test like VDRL (Venereal Disease Research Laboratory) or RPR (Rapid Plasma Reagin).
ICT is essential in TPHA testing for managing data, ensuring accurate record-keeping, and enabling automated analysis of results. ICT tools can also facilitate communication between laboratories, health departments, and clinicians, and improve the overall efficiency and accuracy of syphilis testing and diagnosis.
ICT systems are used to input, store, and analyze patient data and test results. Electronic health records (EHR) systems can be integrated with TPHA testing processes to streamline data management, reduce errors, and provide quick access to patient history and test outcomes.
ICT enhances efficiency by automating repetitive tasks, reduces the likelihood of human error, ensures data security, and improves the speed of processing and delivering results. It also facilitates easy data sharing and reporting, which is crucial for public health monitoring.
Challenges include the initial cost of setting up ICT systems, the need for staff training, potential data privacy concerns, and ensuring that the technology is reliable and properly maintained. Integration with existing systems can also be a complex process.
Laboratory Information Management Systems (LIMS), Electronic Health Records (EHR), and specialized diagnostic software are commonly used. These systems help in tracking samples, managing patient records, and automating test result analysis.
ICT reduces manual data entry, which minimizes human errors. Automated systems can also cross-check results with patient history and other tests, ensuring that the final diagnosis is based on comprehensive and accurate information.
Data security is critical to protect patient confidentiality and comply with regulations such as GDPR or HIPAA. ICT systems must include robust encryption, access controls, and regular security updates to prevent unauthorized access and data breaches.
ICT systems can automatically generate reports that are easy to interpret and share with healthcare providers. These systems can also be programmed to alert medical personnel when a patient’s test results indicate the presence of syphilis, ensuring timely intervention.
Laboratory personnel need training on the specific ICT systems used, including data entry, system navigation, troubleshooting, and understanding how the software integrates with laboratory processes. Ongoing education is often required to stay updated with system upgrades and new functionalities.
Report in 24 hours
Booked 8 times
TPHA
Swift Insights with Immunochromatographic Testing for TPHA
৳800
৳1000
20% OFF
Sample Type
blood
Fasting Required
No
Description
TPHA test is a passive hemagglutination assay based on hemagglutination of erythrocytes sensitized with T. pallidum antigen by antibodies found in the patient’s serum or plasma. It is used for both qualitative and semi-quantitative detection of anti-treponemal antibodies.
Covid Safety
Assured
Free Report
Counselling